• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲型H5N1流感大流行前疫苗初免对CD4 + T细胞反应的影响。

Effect of influenza A(H5N1) vaccine prepandemic priming on CD4+ T-cell responses.

作者信息

Nayak Jennifer L, Richards Katherine A, Yang Hongmei, Treanor John J, Sant Andrea J

机构信息

Division of Infectious Diseases, Department of Pediatrics.

David H. Smith Center for Vaccine Biology and Immunology, Department of Microbiology and Immunology.

出版信息

J Infect Dis. 2015 May 1;211(9):1408-17. doi: 10.1093/infdis/jiu616. Epub 2014 Nov 6.

DOI:10.1093/infdis/jiu616
PMID:25378637
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4425838/
Abstract

INTRODUCTION

Previous priming with avian influenza vaccines results in more rapid and more robust neutralizing antibody responses upon revaccination, but the role CD4(+) T cells play in this process is not currently known.

METHODS

Human subjects previously enrolled in trials of inactivated influenza A(H5N1) vaccines and naive subjects were immunized with an inactivated subunit influenza A/Indonesia/5/05(H5N1) vaccine. Neutralizing antibody responses were measured by a microneutralization assay, and hemagglutinin (HA)-specific and nucleoprotein (NP)-specific CD4(+) T-cell responses were quantified using interferon γ enzyme-linked immunosorbent spot assays.

RESULTS

While vaccination induced barely detectable CD4(+) T-cell responses specific for HA in the previously unprimed group, primed subjects had readily detectable HA-specific memory CD4(+) T cells at baseline and mounted a more robust response to HA-specific epitopes after vaccination. There were no differences between groups when conserved NP-specific CD4(+) T-cell responses were examined. Interestingly, neutralizing antibody responses following revaccination were significantly higher in individuals who mounted a CD4(+) T-cell response to the H5 HA protein, a correlation not observed for NP-specific responses.

CONCLUSIONS

These findings suggest that prepandemic vaccination results in an enriched population of HA-specific CD4(+) T cells that are recruited on rechallenge with a drifted vaccine variant and contribute to more robust and more rapid neutralizing antibody responses.

摘要

引言

先前接种禽流感疫苗会使再次接种时产生更快且更强的中和抗体反应,但目前尚不清楚CD4(+) T细胞在此过程中所起的作用。

方法

将先前参加过甲型流感(H5N1)灭活疫苗试验的人类受试者和未接触过疫苗的受试者用甲型流感/印度尼西亚/5/05(H5N1)灭活亚单位疫苗进行免疫。通过微量中和试验测量中和抗体反应,并使用干扰素γ酶联免疫斑点试验对血凝素(HA)特异性和核蛋白(NP)特异性CD4(+) T细胞反应进行定量分析。

结果

在先前未接种过疫苗的组中,接种疫苗后诱导出的针对HA的CD4(+) T细胞反应几乎检测不到,而接种过疫苗的受试者在基线时就有易于检测到的HA特异性记忆CD4(+) T细胞,并且接种疫苗后对HA特异性表位产生了更强的反应。在检查保守的NP特异性CD4(+) T细胞反应时,两组之间没有差异。有趣的是,对H5 HA蛋白产生CD4(+) T细胞反应的个体再次接种后的中和抗体反应显著更高,而NP特异性反应未观察到这种相关性。

结论

这些发现表明,大流行前的疫苗接种会导致HA特异性CD4(+) T细胞群体增多,当再次接触发生抗原漂移的疫苗毒株时,这些细胞会被募集,并有助于产生更强、更快的中和抗体反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d77d/4425838/6806975c81a1/jiu61605.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d77d/4425838/1f92fe1e4f5c/jiu61601.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d77d/4425838/35222699760f/jiu61602.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d77d/4425838/2d1f44567704/jiu61603.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d77d/4425838/edceeb77fe27/jiu61604.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d77d/4425838/6806975c81a1/jiu61605.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d77d/4425838/1f92fe1e4f5c/jiu61601.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d77d/4425838/35222699760f/jiu61602.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d77d/4425838/2d1f44567704/jiu61603.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d77d/4425838/edceeb77fe27/jiu61604.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d77d/4425838/6806975c81a1/jiu61605.jpg

相似文献

1
Effect of influenza A(H5N1) vaccine prepandemic priming on CD4+ T-cell responses.甲型H5N1流感大流行前疫苗初免对CD4 + T细胞反应的影响。
J Infect Dis. 2015 May 1;211(9):1408-17. doi: 10.1093/infdis/jiu616. Epub 2014 Nov 6.
2
Identification of HLA class II H5N1 hemagglutinin epitopes following subvirion influenza A (H5N1) vaccination.甲型流感病毒(H5N1)亚病毒颗粒疫苗接种后HLA-II类H5N1血凝素表位的鉴定
Vaccine. 2009 Aug 27;27(39):5393-401. doi: 10.1016/j.vaccine.2009.06.081. Epub 2009 Jul 9.
3
Evaluation of the cellular immune responses induced by a non-adjuvanted inactivated whole virus A/H5N1/VN/1203 pandemic influenza vaccine in humans.评估无佐剂灭活全病毒 A/H5N1/VN/1203 大流行流感疫苗在人体中诱导的细胞免疫应答。
Vaccine. 2010 Dec 16;29(2):166-73. doi: 10.1016/j.vaccine.2010.10.065. Epub 2010 Nov 4.
4
Priming with AS03 A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: an open non-randomised extension of a double-blind randomised primary study.AS03 佐剂甲型 H5N1 流感疫苗加强免疫可改善异源加强免疫后的免疫应答动力学、幅度和持久性:一项双盲随机对照初级研究的开放性非随机扩展。
Vaccine. 2010 Jan 8;28(3):849-57. doi: 10.1016/j.vaccine.2009.10.017. Epub 2009 Oct 14.
5
Hemagglutinin-specific CD4 T-cell responses following 2009-pH1N1 inactivated split-vaccine inoculation in humans.2009年甲型H1N1流感病毒裂解灭活疫苗接种后人体血凝素特异性CD4 T细胞反应
Vaccine. 2017 Oct 9;35(42):5644-5652. doi: 10.1016/j.vaccine.2017.08.061. Epub 2017 Sep 13.
6
Intranasal Live Influenza Vaccine Priming Elicits Localized B Cell Responses in Mediastinal Lymph Nodes.鼻内接种活流感疫苗可引发纵隔淋巴结中的局部 B 细胞应答。
J Virol. 2018 Apr 13;92(9). doi: 10.1128/JVI.01970-17. Print 2018 May 1.
7
Immunogenicity and Safety of H5N1 A/Vietnam/1194/2004 (Clade 1) AS03-adjuvanted prepandemic candidate influenza vaccines in children aged 3 to 9 years: a phase ii, randomized, open, controlled study.3 至 9 岁儿童接种 H5N1 A/Vietnam/1194/2004(Clade 1)AS03 佐剂流感疫苗的免疫原性和安全性:一项 II 期、随机、开放、对照研究。
Pediatr Infect Dis J. 2010 Jun;29(6):e35-46. doi: 10.1097/INF.0b013e3181daf921.
8
CD4+ T-cell expansion predicts neutralizing antibody responses to monovalent, inactivated 2009 pandemic influenza A(H1N1) virus subtype H1N1 vaccine.CD4+ T 细胞扩增可预测单价、灭活 2009 年甲型 H1N1 流感病毒亚型 H1N1 疫苗的中和抗体应答。
J Infect Dis. 2013 Jan 15;207(2):297-305. doi: 10.1093/infdis/jis684. Epub 2012 Nov 12.
9
Priming Vaccination With Influenza Virus H5 Hemagglutinin Antigen Significantly Increases the Duration of T cell Responses Induced by a Heterologous H5 Booster Vaccination.用流感病毒H5血凝素抗原进行初次免疫接种可显著延长由异源H5加强免疫接种诱导的T细胞反应持续时间。
J Infect Dis. 2016 Oct 1;214(7):1020-9. doi: 10.1093/infdis/jiw310. Epub 2016 Jul 20.
10
Phase I and II randomised trials of the safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in healthy adults.甲型H5N1流感原型佐剂灭活裂解病毒疫苗在健康成年人中安全性和免疫原性的I期和II期随机试验。
Vaccine. 2008 Aug 5;26(33):4160-7. doi: 10.1016/j.vaccine.2008.05.077. Epub 2008 Jun 13.

引用本文的文献

1
An intranasal adjuvanted, recombinant influenza A/H5 vaccine candidate induces broad priming against diverse influenza A/H5N1 virus clades in a phase I randomized trial in healthy adults.一种鼻内佐剂重组甲型H5流感候选疫苗,在一项针对健康成年人的I期随机试验中,可诱导针对多种甲型H5N1病毒分支产生广泛的初始免疫反应。
Res Sq. 2025 Mar 5:rs.3.rs-6059149. doi: 10.21203/rs.3.rs-6059149/v1.
2
Development of Influenza-Specific CD4 T Cell-Mediated Immunity in Children Following Inactivated Influenza Vaccination.儿童接种流感灭活疫苗后针对流感的特异性 CD4 T 细胞介导免疫的发展。
J Pediatric Infect Dis Soc. 2024 Nov 4;13(10):505-512. doi: 10.1093/jpids/piae095.
3

本文引用的文献

1
Heterologous prime-boost vaccination with MF59-adjuvanted H5 vaccines promotes antibody affinity maturation towards the hemagglutinin HA1 domain and broad H5N1 cross-clade neutralization.用MF59佐剂H5疫苗进行异源初免-加强免疫可促进针对血凝素HA1结构域的抗体亲和力成熟及广泛的H5N1跨分支中和作用。
PLoS One. 2014 Apr 22;9(4):e95496. doi: 10.1371/journal.pone.0095496. eCollection 2014.
2
A live attenuated influenza A(H5N1) vaccine induces long-term immunity in the absence of a primary antibody response.一种减毒活流感 A(H5N1)疫苗可在无初级抗体应答的情况下诱导长期免疫。
J Infect Dis. 2014 Jun 15;209(12):1860-9. doi: 10.1093/infdis/jiu123. Epub 2014 Mar 5.
3
Defining the balance between optimal immunity and immunopathology in influenza virus infection.
确定流感病毒感染中最佳免疫与免疫病理之间的平衡。
Nat Rev Immunol. 2024 Oct;24(10):720-735. doi: 10.1038/s41577-024-01029-1. Epub 2024 May 2.
4
Novel H7N9 influenza immunogen design enhances mobilization of seasonal influenza T cell memory in H3N2 pre-immune mice.新型 H7N9 流感免疫原设计增强了 H3N2 无免疫小鼠季节性流感 T 细胞记忆的动员。
Hum Vaccin Immunother. 2022 Nov 30;18(4):2082191. doi: 10.1080/21645515.2022.2082191. Epub 2022 Jun 15.
5
The Negative Effect of Preexisting Immunity on Influenza Vaccine Responses Transcends the Impact of Vaccine Formulation Type and Vaccination History.既往免疫对流感疫苗反应的负面影响超过了疫苗配方类型和接种史的影响。
J Infect Dis. 2023 Feb 1;227(3):381-390. doi: 10.1093/infdis/jiac068.
6
A single-shot adenoviral vaccine provides hemagglutinin stalk-mediated protection against heterosubtypic influenza challenge in mice.单剂量腺病毒疫苗为小鼠提供血凝素茎介导的针对异型流感病毒挑战的保护。
Mol Ther. 2022 May 4;30(5):2024-2047. doi: 10.1016/j.ymthe.2022.01.011. Epub 2022 Jan 7.
7
Broadly Reactive IgG Responses to Heterologous H5 Prime-Boost Influenza Vaccination Are Shaped by Antigenic Relatedness to Priming Strains.广泛反应性 IgG 对异源 H5 疫苗加强免疫的反应受与初始株抗原相关性的影响。
mBio. 2021 Aug 31;12(4):e0044921. doi: 10.1128/mBio.00449-21. Epub 2021 Jul 6.
8
Robust hepatitis B vaccine-reactive T cell responses in failed humoral immunity.在体液免疫失败时出现强大的乙肝疫苗反应性T细胞应答。
Mol Ther Methods Clin Dev. 2021 Mar 23;21:288-298. doi: 10.1016/j.omtm.2021.03.012. eCollection 2021 Jun 11.
9
Differences in Influenza-Specific CD4 T-Cell Mediated Immunity Following Acute Infection Versus Inactivated Vaccination in Children.儿童急性感染与灭活疫苗接种后流感特异性CD4 T细胞介导免疫的差异
J Infect Dis. 2021 Jun 15;223(12):2164-2173. doi: 10.1093/infdis/jiaa664.
10
Assessment of enhanced influenza vaccination finds that FluAd conveys an advantage in mice and older adults.对强化流感疫苗接种的评估发现,FluAd(流感吸附疫苗)在小鼠和老年人中具有优势。
Clin Transl Immunology. 2020 Feb 3;9(2):e1107. doi: 10.1002/cti2.1107. eCollection 2020.
CD4 T cell help is limiting and selective during the primary B cell response to influenza virus infection.
在原发性B细胞对流感病毒感染的应答过程中,CD4 T细胞的辅助作用是有限且具有选择性的。
J Virol. 2014 Jan;88(1):314-24. doi: 10.1128/JVI.02077-13. Epub 2013 Oct 23.
4
Human circulating influenza-CD4+ ICOS1+IL-21+ T cells expand after vaccination, exert helper function, and predict antibody responses.人类循环中的流感-CD4+ICOS1+IL-21+T 细胞在接种疫苗后会扩增,发挥辅助功能,并预测抗体反应。
Proc Natl Acad Sci U S A. 2013 Aug 27;110(35):14330-5. doi: 10.1073/pnas.1311998110. Epub 2013 Aug 12.
5
Cutting edge: Heterosubtypic influenza infection antagonizes elicitation of immunological reactivity to hemagglutinin.前沿:异源流感感染拮抗针对血凝素的免疫反应性的诱导。
J Immunol. 2013 Aug 1;191(3):1001-5. doi: 10.4049/jimmunol.1203520. Epub 2013 Jun 21.
6
Induction of ICOS+CXCR3+CXCR5+ TH cells correlates with antibody responses to influenza vaccination.诱导 ICOS+CXCR3+CXCR5+TH 细胞与流感疫苗接种的抗体反应相关。
Sci Transl Med. 2013 Mar 13;5(176):176ra32. doi: 10.1126/scitranslmed.3005191.
7
T-cell subsets in the germinal center.生发中心中的 T 细胞亚群。
Immunol Rev. 2013 Mar;252(1):146-55. doi: 10.1111/imr.12031.
8
A randomized clinical trial of an inactivated avian influenza A (H7N7) vaccine.一项关于灭活禽流感 A(H7N7)疫苗的随机临床试验。
PLoS One. 2012;7(12):e49704. doi: 10.1371/journal.pone.0049704. Epub 2012 Dec 11.
9
CD4+ T-cell expansion predicts neutralizing antibody responses to monovalent, inactivated 2009 pandemic influenza A(H1N1) virus subtype H1N1 vaccine.CD4+ T 细胞扩增可预测单价、灭活 2009 年甲型 H1N1 流感病毒亚型 H1N1 疫苗的中和抗体应答。
J Infect Dis. 2013 Jan 15;207(2):297-305. doi: 10.1093/infdis/jis684. Epub 2012 Nov 12.
10
The origins, function, and regulation of T follicular helper cells.滤泡辅助性 T 细胞的起源、功能与调控
J Exp Med. 2012 Jul 2;209(7):1241-53. doi: 10.1084/jem.20120994.